HI SCR36

Department of the Attorney General must conduct a study to determine whether xylazine testing strips should be excluded from Hawaii's drug paraphernalia definition

Study must examine xylazine as a non-FDA-approved veterinary drug increasingly found as an adulterant in illicit drug supplies, particularly mixed with fentanyl, increasing overdose fatality risk

Xylazine was found in illicit drugs in 48 of 50 states as of November 2022 and is associated with one in ten fatal fentanyl overdoses; naloxone does not reverse its effects and no FDA-approved reversal agent exists for humans

Attorney General must submit findings, recommendations, and any proposed legislation to the Legislature no later than 20 days before the 2025 Regular Session convenes

Resolution references other states' efforts to legalize drug-checking equipment like fentanyl test strips through drug paraphernalia law changes to combat overdose deaths